Arafura Rare Earths Confronts a Cash Paradox as Nolans Build Kicks Off

Arafura begins Nolans construction in September with A$723M cash, but October financial close and a share price near its cash value test the fully funded story.

Construction crews are set to mobilise at Arafura Rare Earths' Nolans venture in central Australia this month, yet the company's leadership used its fiscal 2026 results call to concede something unusual: the share price is not behaving as hoped, hovering barely above the value of its own cash pile.

That admission, delivered during Friday's earnings call, has done little to steady the stock. The shares shed 6.2% on the following session to close at EUR 0.1250, having already slipped 7.3% to EUR 0.1240 earlier in the week. Over a 30-day stretch the equity is down 7.5%, though it still clings to a 4.4% gain on a weekly basis.

The valuation riddle

At the close of the fiscal year, Arafura held cash and term deposits of A$723 million, a figure that includes the second tranche of a capital raise placed in May and settled in July. On a pro-forma basis, the war chest exceeds A$900 million.

For a company of this size, that is a formidable balance sheet — and it is precisely the source of the puzzle now being priced into the market. With the market capitalisation sitting only marginally above the cash position, investors are effectively valuing the Nolans project itself at close to nothing. The question hanging over the stock is blunt: does the market believe Arafura can convert its cash into a working mine, or is it already discounting the obstacles along the way?

Groundbreaking on schedule, funding not yet sealed

CEO Darryl Cuzzubbo confirmed that construction begins as planned in September, with the first site preparation works due to start within roughly two weeks. The final investment decision has been taken, and more than A$930 million in equity has been secured, according to the company. Financial close — encompassing the subscriptions from EFA and the German raw materials fund — is slated for October 2026.

That October settlement has become the pivotal event on the calendar. Until it is completed, the "fully funded" label remains a stated intention rather than a closed transaction. Management insists no further capital raises are in the works and that all attention is fixed on building Nolans. Whether that holds depends on whether the October settlement proceeds without friction; any delay would undermine the fully-funded narrative and would likely weigh on the share price.

A further wrinkle: final credit commitments from some debt providers are still outstanding before economic close of the project financing can be reached — an uncertainty that appears to occupy investors more than the operational milestones.

Offtake book takes shape

On the commercial front, Arafura has assembled binding offtake intent agreements that cover a substantial slice of future output. Traxys North America has committed to 500 tonnes of neodymium-praseodymium (NdPr) plus 700 tonnes of dysprosium and terbium, while a separate arrangement with an Indian corporate group adds another 500 tonnes of NdPr and 7 tonnes of dysprosium and terbium per year.

Political backing has arrived as well. The Northern Territory government designated Nolans the first "Significant Project" under the new Territory Coordinator Act, a signal that policymakers and industry are meant to pull in the same direction.

A timeline measured in years, not quarters

Patience is baked into the schedule. The next major earthworks contract is not due to be awarded until the middle of the coming quarter, with completion targeted for mid-2027 so that concrete works can begin. Practical completion of the project is expected around late 2029, followed by a two-year commissioning and ramp-up phase. Full nameplate capacity is not anticipated until late 2031 or early 2032.

To cushion cost pressures, the company has identified potential capital savings of roughly A$200 million through design changes and optimised construction methods.

Management also flagged a sustained recovery in NdPr prices, supported by new price floors in the United States and Japan that should bring greater transparency to the market. Set against that, the company itself acknowledges substantial execution risks stemming from the complexity and remote location of the project, which could produce delays or budget overruns.

What the charts and the losses say

The fiscal 2026 annual loss widened, according to media reports, even as other income increased — a reminder that Arafura is still operating without revenue and remains dependent on external funding. The stock trades about 21% below its 200-day moving average and 3.7% under its 50-day line, and sits 60% beneath its 52-week high of 13 October 2025. Annualised volatility of 61% to 62% underscores how sharply the shares can swing in either direction, as the recent daily drops of more than 6% and 7% demonstrate.

Geopolitical tailwinds add a strategic dimension. Reuters reported on 7 September that some Chinese rare earth firms had halted shipments to the United States amid rising tensions — a development that could enhance the appeal of Western alternatives such as Nolans.

The test ahead

So long as Arafura keeps to its timetable — groundbreaking in September, financial close in October — the investment case for a fully funded, offtake-backed project stays intact. Should that schedule slip, whether through a delayed October settlement or fresh capital needs despite management's assurances, the market is likely to read it as a setback and punish an already fragile share price.

The October financial close is therefore the next real checkpoint. Only after it clears can investors judge whether Nolans is genuinely entering its multi-year build on solid financial footing — or whether the market's scepticism about turning cash into a mine was warranted all along.